| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery
|
Gutgarts, Victoria
|
|
|
26 |
6 |
p. 1071-1076
|
artikel
|
| 2 |
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation
|
Cordas dos Santos, David M.
|
|
|
26 |
6 |
p. 1077-1083
|
artikel
|
| 3 |
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States
|
Mahmoudjafari, Zahra
|
|
|
26 |
6 |
p. 1043-1049
|
artikel
|
| 4 |
Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts
|
Shah, Omid
|
|
|
26 |
6 |
p. 1050-1070
|
artikel
|
| 5 |
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Stern, Anat
|
|
|
26 |
6 |
p. 1195-1202
|
artikel
|
| 6 |
ASTCT Notes
|
|
|
|
26 |
6 |
p. 1238
|
artikel
|
| 7 |
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management
|
Seftel, Matthew D.
|
|
|
26 |
6 |
p. e142-e144
|
artikel
|
| 8 |
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
|
Hsu, Jack W.
|
|
|
26 |
6 |
p. 1210-1217
|
artikel
|
| 9 |
Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations
|
Hofmann, Inga
|
|
|
26 |
6 |
p. 1124-1130
|
artikel
|
| 10 |
Detection and Monitoring of Lineage-Specific Chimerism by Digital Droplet PCR-Based Testing of Deletion/Insertion Polymorphisms
|
Fortschegger, Michaela
|
|
|
26 |
6 |
p. 1218-1224
|
artikel
|
| 11 |
Dietary Intake and Diet Quality of Hematopoietic Stem Cell Transplantation Survivors
|
Farhadfar, Nosha
|
|
|
26 |
6 |
p. 1154-1159
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
26 |
6 |
p. A6
|
artikel
|
| 13 |
Effect of Smoking on Outcomes of Allogeneic Transplantation: A Single-Center Analysis
|
Tamaki, Masaharu
|
|
|
26 |
6 |
p. 1131-1136
|
artikel
|
| 14 |
Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease
|
Chang, Ellen
|
|
|
26 |
6 |
p. 1233-1237
|
artikel
|
| 15 |
Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell Transplantation
|
Zeng, Qiao-Zhu
|
|
|
26 |
6 |
p. 1203-1209
|
artikel
|
| 16 |
Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning Regimen
|
Anurathapan, Usanarat
|
|
|
26 |
6 |
p. 1106-1112
|
artikel
|
| 17 |
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation
|
Hamadani, Mehdi
|
|
|
26 |
6 |
p. 1099-1105
|
artikel
|
| 18 |
Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes
|
Wedge, Eileen
|
|
|
26 |
6 |
p. 1091-1098
|
artikel
|
| 19 |
Improving Quality of Life in Hematopoietic Stem Cell Transplantation Survivors Through a Positive Psychology Intervention
|
Amonoo, Hermioni L.
|
|
|
26 |
6 |
p. 1144-1153
|
artikel
|
| 20 |
Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation
|
Wang, Xing-Lin
|
|
|
26 |
6 |
p. 1171-1178
|
artikel
|
| 21 |
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching
|
Oltolini, Chiara
|
|
|
26 |
6 |
p. 1179-1188
|
artikel
|
| 22 |
Influence of the Insertion Site on Central Venous Catheter-Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Heidenreich, Daniela
|
|
|
26 |
6 |
p. 1189-1194
|
artikel
|
| 23 |
Masthead (Purpose and Scope)
|
|
|
|
26 |
6 |
p. A5
|
artikel
|
| 24 |
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies
|
Arcese, William
|
|
|
26 |
6 |
p. 1113-1118
|
artikel
|
| 25 |
Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research
|
Cho, Hae Lin
|
|
|
26 |
6 |
p. 1225-1232
|
artikel
|
| 26 |
Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis
|
Rashidi, Armin
|
|
|
26 |
6 |
p. e138-e141
|
artikel
|
| 27 |
Officers and Directors of ASTCT
|
|
|
|
26 |
6 |
p. A7
|
artikel
|
| 28 |
Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
|
Salhotra, Amandeep
|
|
|
26 |
6 |
p. 1084-1090
|
artikel
|
| 29 |
Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation
|
Nawas, Mariam T.
|
|
|
26 |
6 |
p. e135-e137
|
artikel
|
| 30 |
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?
|
Ruggiu, Mathilde
|
|
|
26 |
6 |
p. 1160-1170
|
artikel
|
| 31 |
Table of Contents
|
|
|
|
26 |
6 |
p. A12-A16
|
artikel
|
| 32 |
T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Familial Hemophagocytic Lymphohistiocytosis Who Do Not Have Matched Family Donors: Experience in Oman
|
Nazir, Hanan F.
|
|
|
26 |
6 |
p. 1119-1123
|
artikel
|
| 33 |
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era
|
Schmidt, Sarah
|
|
|
26 |
6 |
p. 1137-1143
|
artikel
|
Tijdschrift beschrijving